Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors

Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors

US Patent 10093629 · Granted Oct 9, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nitrogen containing heterocycles as CDK12 inhibitors2025
Heterocyclic compound and use thereof2025
Heterocyclic compound and use thereof2025
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biph2025
3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of M2025
Agents and methods for treating dysproliferative diseases2025
Heterocyclic compound2025
Methods of making a cyclic dinucleotide2024
Heterocyclic compound2024
Heterocyclic compound and application thereof2024
Heterocyclic compound and application thereof2024
Heterocyclic compound2024